World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.

THE SUPPRESSING EFFECT OF rAAV-NKX2.1-siRNA ON THE IN VITRO DEVELOPMENT OF LUNG ADENOCARCINOMA

    https://doi.org/10.4015/S101623721350004XCited by:0 (Source: Crossref)

    The NKX2.1 gene is considered as a proto-onco gene to promote the development of early lung adenocarcinoma. In this study, three kinds of specific siRNAs aiming to NKX2.1 gene were designed to down-regulate the expression of NKX2.1 gene, and constructed into rAAV vectors, respectively. NCI-H1975 cells were infected with the rAAV virus. RT-PCR results showed that all the three siRNAs decreased the expression of NKX2.1 mRNA. WB results show that the expression of NKX2.1 protein was decreased too. It is concluded that the siRNA constructed in rAAV could significantly down-regulate the expression of NKX2.1 gene. Meanwhile, it is proven that the rAAV-NKX2.1-siRNA could inhibit the proliferation and induce apoptosis occurrence in NCI-H1975 cells. In this study, we have expected that the rAAV-NKX2.1-siRNA could be developed into a potential genetic engineering therapeutic virus to suppress the lung AC development and metastasis. The current experiment thus makes a foundation for further research on in vivo gene therapy.